San Francisco Sentry Investment Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,400
Closed -$33K 521
2014
Q3
$33K Hold
2,400
0.02% 350
2014
Q2
$37K Hold
2,400
0.02% 354
2014
Q1
$41K Hold
2,400
0.01% 378
2013
Q4
$31K Hold
2,400
0.01% 387
2013
Q3
$24K Hold
2,400
0.01% 394
2013
Q2
$18K Buy
+2,400
New +$18K 0.01% 423